WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Thursday, August 23, 2018

Electrophysiological signals identify Parkinson's disease subtypes

August 23, 2018, Baylor College of Medicine

Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia

Tremor, rigidity and bradykinesia are well known symptoms of Parkinson's disease, occurring in different combinations in individual patients. However, there have not been any neuronal components that definitively identify the main symptom groupings – including tremor-dominant forms and those without tremor – that can be used to guide treatment approaches.

In a new study, researchers at Baylor College of Medicine have now found neural correlates of two main Parkinson's disease phenotypes that could lead to more precise or personalized  treatments or future neuromodulation technologies to treat this disorder.

The findings appear in the latest edition of the Proceedings of the National Academy of Sciences.

The study focuses on the , a part of the  that makes up the basal ganglia system, which contributes to  control, learning and carrying out behaviors and emotions. It is an area that is associated with certain movement disorders, and is one of the areas that is frequently targeted in the use of deep brain stimulation to treat Parkinson's disease.

"It is an area believed to show electrophysiological abnormalities that accompany the , but very limited data exists," said Dr. Joohi Jimenez-Shahed, associate professor of neurology and director of the Deep Brain Stimulation Program at Baylor. "In our study, we were able to find distinct patterns between these two most common phenotypes when recording local field potentials of the subthalamic nucleus."

Local field potentials are signals made by the combined activity of a group of neurons. Researchers studied 24 patients with Parkinson's disease, dividing them into two groups based on the physical symptoms – tremor-dominant or postural instability and gait difficulty subtypes. By analyzing recordings from multiple microelectrodes in sub-territories of the subthalamic nucleus, they were able to record electrophysiological abnormalities that distinguished between the two sets of motor symptoms.

"Deep brain stimulation of this region is an effective therapy for the treatment of these motor symptoms, but an important goal during this type of surgery is placement of the electrode within the motor territory of the subthalamic nucleus in a location that leads to the greatest therapeutic effect," Jimenez-Shahed said. "Our findings demonstrate the feasibility of using microelectrode local field potentials to identify physiological signatures of Parkinson's disease symptoms to further pinpoint these areas."

Researchers also added that being able to identify these precise areas could lead to more individualized treatment for each patient, thereby resulting in greater benefits and fewer side effects.


More information: Ilknur Telkes et al. Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1810589115



https://medicalxpress.com/news/2018-08-electrophysiological-parkinson-disease-subtypes.html

No comments:

Post a Comment